等待开盘 03-27 09:30:00 美东时间
-0.260
-6.11%
Gainers SciSparc (NASDAQ:SPRC) stock rose 35.1% to $5.2 during Thursday's pre-...
03-12 20:05
SciSparc shares fall after the company agrees to acquire endoscopy-related patents as it pushes into medical devices.
01-14 02:39
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today that it has received a
01-13 05:05
SciSparc Ltd. announced the publication of a Japanese patent for a novel paracetamol-PEA combination, potentially offering safer and more effective pain and fever relief with lower doses and fewer side effects. This innovation could benefit millions worldwide and enhance outcomes for various pain types.
2025-05-27 11:32
Shares of Paymentus Holdings, Inc. (NYSE:PAY) rose sharply in today's pre-marke...
2025-03-11 18:55
SciSparc Ltd (NASDAQ:SPRC) shares are ripping higher Monday after the company announced that its collaboration with Clearmind Medicine Inc (NASDAQ:CMND) led to a patent application for psychedelic therapy targeting cocaine addiction.
2025-03-10 23:49
SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that
2025-03-10 19:49
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
2024-09-18 00:31
Shares of Intel Corporation (NASDAQ:INTC) rose sharply in today's pre-market tr...
2024-09-17 17:48
Reported August 28: SciSparc Files For Sale Of Up To 21M Ordinary Shares Under $20M SEPA Agreement; Shares Priced At 97% Of Market Value; May Receive Up To $8.82M
2024-08-29 20:46